In Vitro And In Vivo Liposomes Formulation Studies Of Orthosiphon Stamineus Extract For Lung Cancer

In Vitro And In Vivo Liposomes Formulation Studies Of Orthosiphon Stamineus Extract For Lung Cancer

In this study, anti-angiogenic and anti-tumour potencies of the standardized 50% ethanol extract of Orthosiphon stamineus leaves (O.S extract) were assessed towards human lung cancer in vitro and in vivo. Liposomal drug delivery system was developed from the O.S extract to improve bioavailability, e...

Full description

Saved in:
Bibliographic Details
Main Author: Baharetha, Hussein Mahfoudh Saeed
Format: Thesis
Language:English
Published: 2018
Subjects:
RS1-441 Pharmacy and materia medica
Online Access:http://eprints.usm.my/49757/1/HUSSEIN%20MAHFOUDH%20SAEED%20BAHARETHA_hj.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-usm-ep.49757
record_format uketd_dc
spelling my-usm-ep.497572021-08-26T10:39:28Z In Vitro And In Vivo Liposomes Formulation Studies Of Orthosiphon Stamineus Extract For Lung Cancer 2018-08 Baharetha, Hussein Mahfoudh Saeed RS1-441 Pharmacy and materia medica In this study, anti-angiogenic and anti-tumour potencies of the standardized 50% ethanol extract of Orthosiphon stamineus leaves (O.S extract) were assessed towards human lung cancer in vitro and in vivo. Liposomal drug delivery system was developed from the O.S extract to improve bioavailability, efficacy, stability and safety profiles of the O.S extract. Three formulation was developed based on the extract : phospholipid ratio, phospholipid and cholesterol content. NP2, which is a formulation consisting of 1:1 extract to phosphatidylcholine ratio with 20% cholesterol, showed optimum entrapment efficiency, integrity, stability and efficacy of the liposomes. Liposomes were characterized qualitatively and quantitatively using light, TEM and SEM microscopy (which shows intact formation of nano-spherical shaped vesicles with mostly smooth surface and completely closed bilayer membrane), zetasizer and zeta potential (which reports anionic nano-vesicles with dynamic diameter 125-132 nm). NP2 shown significantly better release properties of the bioactive compounds and good stability profile than the O.S extract for six months stability studies (P≤0.05) at 30ºC or below. The O.S extract and the liposomes partially inhibited proliferation of human lung adenocarcinoma (A549) and human normal endothelial cells (EA.hy926), and revealed potent anti-angiogenic potency as in ex vivo assay of rat aortic ring. TEM analysis of A549 cells shows obvious apoptotic morphological alterations, with indication of the cellular uptake of the liposomes. It also inhibited in vitro colonization, cells invasion and cell migration in a dose–time dependent manner. Protein array and dual-luciferase studies show overexpression of various apoptotic-regulating proteins, including TGF-β and MAPK/ERK, TRAILR-1, Bid, Bax, caspase 3, IGFBP-1 and IGFBP-5; and down-regulation of some other pathways, such as WNT, Bcl-2, cIAP-2, livin, IGFBP-3, IGFBP-6 and IGF-1SR. The O.S extract and NP2 inhibited EA.hy926 cells colonization, migration and tube formation, and also down-regulated the expression of VEGF and HIF-1α indicating anti-angiogenic activity. In vivo studies reveal potent anti-tumour activity of the O.S extract and the NP2 liposome formulation towards human lung cancer in xenograft tumour model and decreased VEGF expression. Pharmacokinetic studies show that the liposomes increased oral bioavailability and improved pharmacokinetic profile. Acute and sub-acute toxicity studies reveal good margin of safety for the NP2 formulation. The liposomes (NP2) show significantly better efficiencies with enhanced bioavailability and stability compared to the non-formulated O.S extract (E) (P≤0.05). All-in-all, the results of this study indicates that the O.S extract has potent anti-tumour activity towards lung carcinoma and the NP2 liposome formulation improves its anti-tumour efficacy. 2018-08 Thesis http://eprints.usm.my/49757/ http://eprints.usm.my/49757/1/HUSSEIN%20MAHFOUDH%20SAEED%20BAHARETHA_hj.pdf application/pdf en public phd doctoral Universiti Sains Malaysia Pusat Pengajian Sains Farmasi
institution Universiti Sains Malaysia
collection USM Institutional Repository
language English
topic RS1-441 Pharmacy and materia medica
spellingShingle RS1-441 Pharmacy and materia medica
Baharetha, Hussein Mahfoudh Saeed
In Vitro And In Vivo Liposomes Formulation Studies Of Orthosiphon Stamineus Extract For Lung Cancer
description In this study, anti-angiogenic and anti-tumour potencies of the standardized 50% ethanol extract of Orthosiphon stamineus leaves (O.S extract) were assessed towards human lung cancer in vitro and in vivo. Liposomal drug delivery system was developed from the O.S extract to improve bioavailability, efficacy, stability and safety profiles of the O.S extract. Three formulation was developed based on the extract : phospholipid ratio, phospholipid and cholesterol content. NP2, which is a formulation consisting of 1:1 extract to phosphatidylcholine ratio with 20% cholesterol, showed optimum entrapment efficiency, integrity, stability and efficacy of the liposomes. Liposomes were characterized qualitatively and quantitatively using light, TEM and SEM microscopy (which shows intact formation of nano-spherical shaped vesicles with mostly smooth surface and completely closed bilayer membrane), zetasizer and zeta potential (which reports anionic nano-vesicles with dynamic diameter 125-132 nm). NP2 shown significantly better release properties of the bioactive compounds and good stability profile than the O.S extract for six months stability studies (P≤0.05) at 30ºC or below. The O.S extract and the liposomes partially inhibited proliferation of human lung adenocarcinoma (A549) and human normal endothelial cells (EA.hy926), and revealed potent anti-angiogenic potency as in ex vivo assay of rat aortic ring. TEM analysis of A549 cells shows obvious apoptotic morphological alterations, with indication of the cellular uptake of the liposomes. It also inhibited in vitro colonization, cells invasion and cell migration in a dose–time dependent manner. Protein array and dual-luciferase studies show overexpression of various apoptotic-regulating proteins, including TGF-β and MAPK/ERK, TRAILR-1, Bid, Bax, caspase 3, IGFBP-1 and IGFBP-5; and down-regulation of some other pathways, such as WNT, Bcl-2, cIAP-2, livin, IGFBP-3, IGFBP-6 and IGF-1SR. The O.S extract and NP2 inhibited EA.hy926 cells colonization, migration and tube formation, and also down-regulated the expression of VEGF and HIF-1α indicating anti-angiogenic activity. In vivo studies reveal potent anti-tumour activity of the O.S extract and the NP2 liposome formulation towards human lung cancer in xenograft tumour model and decreased VEGF expression. Pharmacokinetic studies show that the liposomes increased oral bioavailability and improved pharmacokinetic profile. Acute and sub-acute toxicity studies reveal good margin of safety for the NP2 formulation. The liposomes (NP2) show significantly better efficiencies with enhanced bioavailability and stability compared to the non-formulated O.S extract (E) (P≤0.05). All-in-all, the results of this study indicates that the O.S extract has potent anti-tumour activity towards lung carcinoma and the NP2 liposome formulation improves its anti-tumour efficacy.
format Thesis
qualification_name Doctor of Philosophy (PhD.)
qualification_level Doctorate
author Baharetha, Hussein Mahfoudh Saeed
author_facet Baharetha, Hussein Mahfoudh Saeed
author_sort Baharetha, Hussein Mahfoudh Saeed
title In Vitro And In Vivo Liposomes Formulation Studies Of Orthosiphon Stamineus Extract For Lung Cancer
title_short In Vitro And In Vivo Liposomes Formulation Studies Of Orthosiphon Stamineus Extract For Lung Cancer
title_full In Vitro And In Vivo Liposomes Formulation Studies Of Orthosiphon Stamineus Extract For Lung Cancer
title_fullStr In Vitro And In Vivo Liposomes Formulation Studies Of Orthosiphon Stamineus Extract For Lung Cancer
title_full_unstemmed In Vitro And In Vivo Liposomes Formulation Studies Of Orthosiphon Stamineus Extract For Lung Cancer
title_sort in vitro and in vivo liposomes formulation studies of orthosiphon stamineus extract for lung cancer
granting_institution Universiti Sains Malaysia
granting_department Pusat Pengajian Sains Farmasi
publishDate 2018
url http://eprints.usm.my/49757/1/HUSSEIN%20MAHFOUDH%20SAEED%20BAHARETHA_hj.pdf
_version_ 1747822014085726208

Similar Items